| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 08/29/2007 | EP1824496A1 Compositions comprising scyllo-inositol derivatives and methods to treat disorders of protein aggregation |
| 08/29/2007 | EP1824495A2 Finasteride, dutasteride and related compounds for preventing/treating neurologically-associated disorders |
| 08/29/2007 | EP1824494A1 Topical drug delivery system |
| 08/29/2007 | EP1824493A1 Oral suspension comprising meloxicam |
| 08/29/2007 | EP1824492A2 Cancer treatment method |
| 08/29/2007 | EP1824491A1 Monocompartment osmotic-controlled delivery system of doxazosin |
| 08/29/2007 | EP1824490A1 Piperazinyl-pyridine analogues |
| 08/29/2007 | EP1824488A1 Phycotoxins and uses thereof |
| 08/29/2007 | EP1824487A1 The use of 4-(s)-(4-acetyl-piperazin-1-yl)-2-(r)-(4-fluoro-2-methyl-phenyl)-piperidine-1-carboxilic acid, [1-(r)-(3,5-bis-trifluoromethyl-phenyl)-ethyl]-methylamide for the treatment of overactive bladder |
| 08/29/2007 | EP1824486A1 Benzdioxane piperazine derivatives with a combination of affinity for dopamine-d2 receptors and serotonin reuptake sites |
| 08/29/2007 | EP1824485A1 Pharmaceutical formulation for increasing solubility of 10-hydroxycamptothecin compounds in non-aqueous polar solvents |
| 08/29/2007 | EP1824484A1 Drugs and prodrugs useful for the treatment of energy balance in ruminants |
| 08/29/2007 | EP1824483A2 Muscarinic acetylcholine receptor antagonists |
| 08/29/2007 | EP1824482A1 3, 5-DISUBSTITUTED AND 3,5,7-TRISUBSTITUTED-3H-OXAZOLO AND 3H-THIAZOLO [4,5-d]PYRIMIDIN-2-ONE COMPOUNDS AND PRODRUGS THEREOF |
| 08/29/2007 | EP1824481A1 Use of ribose-cysteine to treat hypoxia by enhancing delivery of glutathione and atp levels in cells |
| 08/29/2007 | EP1824480A1 Phenylpiperazine derivatives with a combination of partial dopamine-d2 receptor agonism and serotonin reuptake inhibition |
| 08/29/2007 | EP1824479A1 Phenylpiperazine derivatives with a combination of partial dopamine-d2 receptor agonism and serotonin reuptake inhibition |
| 08/29/2007 | EP1824478A2 Novel uses for estrogen beta agonists |
| 08/29/2007 | EP1824477A1 Use of staurosporine derivatives for the treatment of multiple myeloma |
| 08/29/2007 | EP1824476A2 Tetrahydrocarbazole derivatives for treating flaviridae viruses |
| 08/29/2007 | EP1824475A1 Methods for purifying trans-(-)-delta9-tetrahydrocannabinol and trans-(+)-delta9-tetrahydrocannabinol |
| 08/29/2007 | EP1824474A1 Anthelmintic composition |
| 08/29/2007 | EP1824473A1 Radioactive chitosan complex having an improved stabilized gelatin in administering them to the body and their preparation method |
| 08/29/2007 | EP1824472A1 Use of acetyl l-carnitine for the treatment of fibromyalgic syndrome |
| 08/29/2007 | EP1824471A2 Modulation of nitric oxide synthases by betaines |
| 08/29/2007 | EP1824470A2 Method for extending lifespan and delaying the onset of age-related disease |
| 08/29/2007 | EP1824469A1 A method of modulating b cell functioning |
| 08/29/2007 | EP1824468A2 Glycogen synthase kinase-3 inhibitors |
| 08/29/2007 | EP1824467A2 Apogossypolone and the uses thereof |
| 08/29/2007 | EP1824466A2 Compositions and methods for pulmonary conditions |
| 08/29/2007 | EP1824465A2 Vulnerable plaque treatment |
| 08/29/2007 | EP1824464A1 Use of a 5-ht6 agonist for the treatment and prevention of neurodegenerative disorders |
| 08/29/2007 | EP1824463A1 Pharmaceutical compositions for the treatment of cellulite |
| 08/29/2007 | EP1824462A2 Composition and method for the treatment of tauopathies |
| 08/29/2007 | EP1824457A1 Multiparticulate form of administration, comprising nucleic acid-containing mucoadhesive active ingredients, and method for producing said form of administration |
| 08/29/2007 | EP1824456A2 Micronised azodicarbonamide, the preparation and use thereof |
| 08/29/2007 | EP1824454A2 Targeted iron chelator delivery system |
| 08/29/2007 | EP1746993A4 Controlled release metformin compositions |
| 08/29/2007 | EP1725538B1 Pyridazinone ureas as antagonists of a4 integrins |
| 08/29/2007 | EP1694656B1 Benzoxazine derivatives and uses thereof |
| 08/29/2007 | EP1670767A4 Resolution of a narwedine amide derivative |
| 08/29/2007 | EP1644385B1 Silicon compounds and their use |
| 08/29/2007 | EP1643998B1 Dual nk1/nk3 antagonists for treating schizophrenia |
| 08/29/2007 | EP1603930B1 Protein-bound derivatives of platinum complexes containing cyclobutane 1.1-dicarboxyllate ligands |
| 08/29/2007 | EP1590344A4 Anti-cancer medicaments |
| 08/29/2007 | EP1572195B1 Natural vitamin e compositions with superior antioxidant potency |
| 08/29/2007 | EP1569631B1 A method of preventing and/or treating asthma using parabromophenacyl bromide (pbpb) |
| 08/29/2007 | EP1562938B1 Heteroaryl-pyrimidine derivatives as jak inhibitors |
| 08/29/2007 | EP1558615B1 Purine compounds and use thereof as cannabinoid receptor ligands |
| 08/29/2007 | EP1556041B1 New crystalline hydrates of the sodium salt of 3-pyridyl-1-hydroxyethylidene-1,1-bisphosphonic acid |
| 08/29/2007 | EP1556012B1 Method for producing solid galenic formulations using a crosslinked non-thermoplastic carrier |
| 08/29/2007 | EP1517899B1 Broadspectrum substituted benzisoxazole sulfonamide hiv protease inhibitors |
| 08/29/2007 | EP1506167B1 Hydroxy tetrahydro-naphthalenylurea derivatives |
| 08/29/2007 | EP1485138A4 Medical device for delivering biologically active material |
| 08/29/2007 | EP1450847A4 Apo2 ligand/trail formulations |
| 08/29/2007 | EP1450813B1 Antagonists of prostaglandin receptors ep2 and/or ep4 for the treatment of menorrhagia |
| 08/29/2007 | EP1441700B1 Method for the preparation of a pharmaceutical composition comprising 5-aminosalicyclic acid for use in treatment of ulcerative colitis and crohn's disease |
| 08/29/2007 | EP1425019B1 Pharmaceutical composition comprising an androgen |
| 08/29/2007 | EP1425006B1 Reference control for high-sensitivity c-reactive protein testing |
| 08/29/2007 | EP1423126B1 Treatment of hyperproliferative conditions of body surfaces |
| 08/29/2007 | EP1423125B1 Use of non-feminizing estrogens as retinoprotective agents for the treatment of glaucoma |
| 08/29/2007 | EP1414961B1 Novel oligoribonucleotide derivatives for the targeted inhibition of gene expression |
| 08/29/2007 | EP1412368B1 Sugar derivatives of hydromorphone, dihydromorphine and dihydroisomorphine, compositions thereof and uses for treating or preventing pain |
| 08/29/2007 | EP1406907B1 Antitumoral derivatives of et-743 |
| 08/29/2007 | EP1404652B1 A novel alkaloid derivative and a pharmaceutical composition containing the same |
| 08/29/2007 | EP1351934B1 Naphthalene derivatives which bind to the ep4 receptor |
| 08/29/2007 | EP1347754B1 Compositions for adhesion prevention |
| 08/29/2007 | EP1337522B1 farnesyl protein transferase inhibitors |
| 08/29/2007 | EP1333840B9 M. tuberculosis chaperonin 60.1 and uses thereof |
| 08/29/2007 | EP1306083A4 Emulsion of perfluororganic compounds for medical purposes, method for producing said emulsion and methods for curing and preventing diseases with the aid of the emulsion |
| 08/29/2007 | EP1268431B1 3-cyanoquinolines,3-cyano-1,6-naphthyridines, and 3-cyano-1,7-naphthyridines as protein kinase inhibitors |
| 08/29/2007 | EP1239814B1 Use of the residues from wine production |
| 08/29/2007 | EP1140078B1 Benzimidazole vascular damaging agents |
| 08/29/2007 | EP1140024B1 Particles for oral delivery of peptides and proteins |
| 08/29/2007 | EP1121361B1 Pyrazolo-triazine derivatives as ligands for gaba receptors |
| 08/29/2007 | EP1105136B1 Method for treating ocular neovascular diseases |
| 08/29/2007 | EP1096932B1 Antihypertensive combination of valsartan and calcium channel blocker |
| 08/29/2007 | EP1054963B1 Sequences of an ih ionic channel and the use thereof |
| 08/29/2007 | EP1024814B1 Use of antifungal agents for the topical treatment of fungus-induced mucositis |
| 08/29/2007 | CN101027560A Human G protein-coupled receptor for the treatment of hyperglycemia and related disorders and its modulator |
| 08/29/2007 | CN101027405A Process for synthesis of derivatives, compound library, method for making the mase, and screening method |
| 08/29/2007 | CN101027312A 抗病毒化合物 Antiviral compounds |
| 08/29/2007 | CN101027309A Enantiomers of selected fused pyrimidones and uses in the treatment and prevention of cancer |
| 08/29/2007 | CN101027304A Synthesis of 6,7-dihydro-5H-imidazo[1,2-A]imidazole-3-sulfonic acid amides |
| 08/29/2007 | CN101027303A Imidazo 4,5-dpyrimidines, their uses and methods of preparation |
| 08/29/2007 | CN101027302A Pyrrolo-pyridine kinase modulators |
| 08/29/2007 | CN101027301A Fused ring azadecalin glucocorticoid receptor modulators |
| 08/29/2007 | CN101027300A Novel azabicyclic aryl derivatives and their medical use |
| 08/29/2007 | CN101027299A Carbo- and hetero-cyclic antibiotics and use thereof |
| 08/29/2007 | CN101027297A Macrocyclic beta-secretase inhibitors |
| 08/29/2007 | CN101027296A Oxazolidinone compounds and compositions and methods related thereto |
| 08/29/2007 | CN101027295A Chemical compounds and pharmaceutical compositions containing them for the treatment of inflammatory disorders |
| 08/29/2007 | CN101027294A Phenyl DIAZEPAN carboxamides and annelated phenyl piperazine carboxamides containing oxygen and used as dopamine D3 antagonists |
| 08/29/2007 | CN101027292A Compounds, compositions containing them, preparation thereof and uses thereof |
| 08/29/2007 | CN101027291A Benzimidazole derivatives and their use as cannabinoid receptor ligands |
| 08/29/2007 | CN101027290A Novel 2,3-phthalazinone derivatives, as AURORA-A kinase inhibitors |
| 08/29/2007 | CN101027288A HIV inhibiting 5-substituted pyrimidines |
| 08/29/2007 | CN101027287A Method of manufacturing 2-chloro-4-nitroimidazole |
| 08/29/2007 | CN101027286A Indozolone derivatives as 11b-HSD1 inhibitors |
| 08/29/2007 | CN101027284A Novel crystalline form of (3-cyano-1H-indol-7-yl)-[4-(4-fluorophenethyl)-piperazine-1-yl]-methanone hydrochloride |